BASILEA
Dead / Abandoned — Abandoned — no statement of use filed (as of 08 May 2023)
What this means for you
This application is over — abandoned 08 May 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88633518
- Mark type
- Design + words
- Filed
- 27 Sept 2019
- Published for opposition
- 11 Feb 2020
- Abandoned
- 08 May 2023
- Attorney of record
- Evan A. Raynes
Goods and services
- Class 001 — Chemicals: Chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions, the treatment of infections and diseases and in the research and development of pharmaceuticals in the treatment of dermatological conditions, the treatment of infections and diseases; diagnostic preparations for scientific clinical use; diagnostic reagents for clinical or medical laboratory use
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of dermatological conditions, namely, eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of infections caused by bacteria, fungi, viruses, and rheumatoid arthritis; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of oncology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of gastroenterology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of neurology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of gynecology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of urology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of cardiology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of endocrinology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of nephrology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of hematology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of allergies; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of immunology; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of psychiatry; Pharmaceutical and veterinary products and preparations, namely, for the treatment and prevention of diseases, disorders and conditions in the area of anesthesiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of rheumatology; diagnostic preparations for medical clinical purposes; clinical medical reagents; all of the aforesaid for prescription only
- Class 042 — Scientific and technological services: Research and development services for third parties in the field of chemical substances, pharmaceutical and veterinary products and preparations
Owner
- Basilea Pharmaceutica AG, Basel, CH
- Basilea Pharmaceutica AG, Basel, CH
Prosecution history
- 08 May 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 08 May 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 06 Oct 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Oct 2022 — SOU EXTENSION 5 GRANTED
- 21 Sept 2022 — SOU EXTENSION 5 FILED
- 02 Oct 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 21 Sept 2022 — SOU TEAS EXTENSION RECEIVED
- 11 Mar 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Mar 2022 — SOU EXTENSION 4 GRANTED
- 09 Mar 2022 — SOU EXTENSION 4 FILED
- 09 Mar 2022 — SOU TEAS EXTENSION RECEIVED
- 25 Sept 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Sept 2021 — SOU EXTENSION 3 GRANTED
- 23 Sept 2021 — SOU EXTENSION 3 FILED
- 23 Sept 2021 — SOU TEAS EXTENSION RECEIVED